Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
SGHT
#3642
Sight Sciences, Inc. Common Stock
3.8
2
USD
+3.52%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+3.52%
Changement Mensuel
+3.24%
Evolution sur 6 mois
+13.35%
Changement Annuel
+58.51%
Clôture Précédente
3.6
9
Open
3.8
2
Bid
Ask
Low
3.8
2
High
3.8
2
Volume
34
Marchés
Actions des Marchés US
Soins de Santé
SGHT
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
47.59 M
48.42 M
49.55 M
51.33 M
54.01 M
—
Valuation ratios
Enterprise value
608.07 M
444.84 M
148.52 M
105.85 M
376.6 M
715.68 M
Price to earnings ratio
—
-6.84
-4.47
-3.53
-10.72
-21.29
Price to sales ratio
—
8.26
3.06
2.28
5.35
11.97
Price to cash flow ratio
—
-7.76
-5.26
-8.16
-13.93
-34.14
Price to book ratio
—
3.68
2.06
2.09
6.47
8.03
Enterprise value to EBITDA ratio
-12.16
-5.41
-2.64
-2.14
-10.3
-17.57
Profitability ratios
Return on assets %
-0.22
-0.4
-0.33
-0.36
-0.33
-0.31
Return on equity %
-0.27
-0.54
-0.46
-0.59
-0.6
-0.55
Return on invested capital %
-1 538.73
-2 005.96
-1 015.04
-926.57
-770.49
-876.37
Gross margin %
82.41
82.67
85.34
85.5
86.17
344.65
Operating margin %
-105.15
-117.7
-70.66
-63.27
-47.95
-196.5
EBITDA margin %
-102.43
-115.78
-69.14
-62.38
-47.32
-193.95
Net margin %
-128.61
-120.9
-68.53
-64.49
-49.67
-203.33
Liquidity ratios
Quick ratio
20.26
11.43
12.65
8.63
9.52
37.92
Current ratio
20.52
11.77
13.29
9.04
10.22
40.3
Inventory turnover
2.48
2.58
1.7
1.63
1.52
1.6
Asset turnover
0.17
0.29
0.43
0.52
0.6
0.63
Solvency ratios
Debt to assets ratio
0.12
0.16
0.2
0.28
0.35
1.33
Debt to equity ratio
0.14
0.21
0.28
0.45
0.63
2.33
Long term debt to total assets ratio
0.12
0.16
0.19
0.28
0.35
1.33
Long term debt to total equity ratio
0.14
0.21
0.26
0.45
0.63
2.33
Per share metrics
Operating cash flow per share
—
-1.59
-0.97
-0.45
-0.57
-0.57
EBIT per share
—
-1.75
-1.18
-1.01
-0.71
-0.72
EBITDA per share
—
-1.73
-1.15
-0.99
-0.7
-0.71
Total debt per share
—
0.7
0.7
0.79
0.77
3.08
Cash per share
—
3.87
2.84
2.4
1.76
7.61
Net current asset value per share
—
4.38
3.35
2.79
2.16
9.11
Tangible book value per share
—
3.35
2.47
1.75
1.23
5.32
Working capital per share
—
4.01
3.1
2.48
1.95
8.21
Book value per share
—
3.35
2.47
1.75
1.23
5.32
Nouvelles
Sight Sciences remporte 34 M$ contre Alcon et obtient des royalties
William Blair réitère sa notation sur Sight Sciences grâce au contrôle des dépenses
William Blair reiterates Sight Sciences stock rating on expense control
Sight Sciences, Inc. (SGHT) Q4 2025 Earnings Call Transcript
Sight Sciences (SGHT) Reports Q4 Earnings: What Key Metrics Have to Say
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates
Le BPA de Sight Sciences a dépassé les attentes de 0,07$, le CA a surpassé les prévisions
Sight Sciences earnings beat by $0.07, revenue topped estimates
Broadcom, Veeva Systems, Okta and more set to report earnings Wednesday
Stifel relève l’objectif de cours de Sight Sciences sur la base d’une enquête TearCare
Stifel raises Sight Sciences stock price target on TearCare survey
RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates